Go to Client Portal

The Impact of Shifting Site of Care on Clinical Research: A Vascular Office-Based Laboratory Approach



Date(s) - May 14, 2024
10:00 AM - 11:00 AM CT

Register Now


Over the last several years, vascular procedures have continued to shift from the traditional hospital setting into the outpatient setting, including Ambulatory Surgery Centers (ASC) and Office-Based Laboratories (OBL). This shifting of care has come with improvements in patient experience and care during stays while providing a better work-life balance for physicians. However, despite the movement of procedures, clinical research has been largely maintained in the hospital setting leaving many patients and physicians without access to clinical trials. As we look to the future, OBLs and ASCs have an opportunity to expand this access to their patient population. However, several items will need to be evaluated.

To learn more, join our panel discussion where Kenneth Ouriel, MD, MBA (Chief Medical Officer, NAMSA) will moderate a discussion diving into this topic with vascular physician leaders, industry experts, and clinical research professionals.


Attendees of this panel discussion can expect to hear expert opinions on:

  1. The Benefits of OBLs and ASCs in clinical research
  2. Getting an OBL or ASC started in clinical research
  3. Identifying and resolving barriers to participating in clinical research at an OBL or ASC
  4. Patient benefit from having access to clinical research at the OBL or ASC


Don’t miss out on this insightful event to explore the evolving landscape of vascular healthcare and the pivotal role of OBLs and ASCs in advancing clinical research!


*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com

NAMSA uses a third-party provider, GoToWebcast, to host NAMSA webinars. For information related to GoToWebcast’s privacy policy and utilization of information, please contact GoToWebcast directly.


Kenneth Ouriel

Chief Medical Officer

Dr. Kenneth Ouriel is one of the country’s top vascular surgeons publishing more than 300 scientific articles and three texbooks. He is a frequent presenter at international conferences and brings over 30 years of experience in medical research. Dr. Ouriel began his undergraduate studies at the University of Rochester. After earning his bachelor’s in biology and psychology he studied medicine at the Pritzker School of Medicine at the University of Chicago. After graduating from Pritzker with honors in 1981, he became a general surgery resident at the University of Rochester, where he completed a vascular surgery fellowship and remained as a faculty member for 11 years. In 1998, he joined the Cleveland Clinic as its chief of vascular surgery and later became its chief of surgery overseeing 340 surgeons. In 2007, he led a Cleveland Clinic team in Abu Dhabi where they helped establish world-class care at the Sheik Khalifa Medical Center. In 2008, Ken served as senior vice president and chief of international operations at New York-Presbyterian Hospital while earning an MBA from Columbia University and the London Business School. In 2010, Ken founded Syntactx, a medical device development solution company which has now become part of NAMSA.

Corie Diaz

Corie Diaz, BA, MBA

Global Director, Clinical Operations

Corie Diaz has been in the industry for over 20 years with over 15 years focused on medical devices, primarily within the cardiovascular space. She graduated with a Bachelor of Arts in Biological Sciences and a Master of Business Administration from Rutgers University.

Corie has extensive experience in the management of clinical trials in North America, Europe and Asia-Pacific. In addition to leading Clinical Study Management, Site Management and Monitoring activities at NAMSA, Corie provides oversight of clinical research processes and delivery of services Clients. Her expertise encompasses all facets of research from trial design to execution, from studies of varying sizes and complexities within the medical device and pharmaceutical industries.